Adjuvant Treatment of Recurrent Gastrointestinal Cancer Based on the Concept of Rapid Eehabilitation
Frontiers in Medical Science Research · 2021
DOI: 10.25236/fmsr.2021.030104 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Medical Science Research, 2021.
Abstract (Originalsprache)
Rapid Rehabilitation Surgery (FTS) refers to the method of relieving and reducing the occurrence of surgical stress and complications and accelerating the postoperative rehabilitation of patients through close cooperation between medical care and nursing. Rapid rehabilitation surgery includes preoperative education for patients, reasonable preoperative preparation, good anesthesia and treatment during operation, fine surgical techniques, effective postoperative analgesia, and minimizing various stress reaction factors during perioperative period. Most patients lack understanding of the concept of rapid rehabilitation surgery. The concept of rapid rehabilitation surgery encourages early getting out of bed, early extubation, early recovery of enteral nutrition support, and restriction of fluid replacement. It is different from the public's understanding of postoperative surgery, which may lead to psychological stress in patients. It is of great clinical significance to optimize the nursing measures of the concept of rapid rehabilitation surgery and formulate a nursing plan that accords with the actual situation of patients.
Zitieren
APA
(2021). Adjuvant Treatment of Recurrent Gastrointestinal Cancer Based on the Concept of Rapid Eehabilitation. Frontiers in Medical Science Research. https://doi.org/10.25236/fmsr.2021.030104
Vancouver
Adjuvant Treatment of Recurrent Gastrointestinal Cancer Based on the Concept of Rapid Eehabilitation. Frontiers in Medical Science Research. 2021. doi:10.25236/fmsr.2021.030104
BibTeX
@article{euvimed2021,
title = {Adjuvant Treatment of Recurrent Gastrointestinal Cancer Based on the Concept of Rapid Eehabilitation},
journal = {Frontiers in Medical Science Research},
year = {2021},
doi = {10.25236/fmsr.2021.030104}
}
EUVIMED